Genomics England has revealed part of how it plans to turn the huge amount of data generated by the 100,000 Genomes Project into insights into rare diseases and cancers. From today, British researchers who want to work with the data can apply to access the resource.
Over the past few decades, the harsh realities of complex biology have brought back to Earth some pie-in-the-sky projections about the value of genomics in biotech R&D. But the industry still devotes the vast majority of research spending to target-based drug development, an imbalance that could be a factor in Big Pharma's slumping efficiency rates.
Google is going after your genome. The search giant has spent the past 18 months building its Google Genomics platform and pitching it to researchers as a way to store human genomes for $25 each per year.
IBM has made another foray into healthcare research. The latest collaboration sees the tech veteran team up with Cleveland Clinic to use Watson in genomics cancer research.
Geisinger Health System has added another component to the genomic variant database it is helping to create as part of a $25 million National Institutes of Health initiative. The new addition gives patients the option to submit their genetic test results and other health information to a registry.
The National Science Foundation has awarded Cornell University a grant to cut the time it takes to transfer data.
While there is a well-established path from seed funding to exit for web startups, genomics plays with big ambitions require investors with deep pockets and an appetite for risk. Bryan Johnson seemingly has both and has set up a $100 million fund with the objective of turning "crazy" ideas into "viable" businesses.
Faced with the challenge of how to handle data from the 100,000 exomes it intends to sequence, Regeneron has struck a deal with DNAnexus to access cloud-based infrastructure.The biotech is working with DNAnexus through the Regeneron Genetics Center it established for the sequencing project.
The list of life science data projects underpinned by Google keeps getting longer. Having signed up to the BRAIN Initiative last week, Google has now teamed up with ISB and SRA International to work on a project for the National Cancer Institute.
With Oxford Nanopore's oversubscribed offering pulling in $59 million (£35 million), the British startup has the money to scale up production of its sequencer while developing new uses for the underlying technology.